References
- Johnsen, H.E., Bjorkstrand, B., Carlson, K., Gruber, A., Blystad, A., Fast, A., Boesen, A.M., Bjorkholm, M., Sallerfors, B., Ruutu, T., Carneskog, J., Malm, A., Geisler, C., Lehtinen, M., Schroder, H., Brinch, L., Remes, K., Tidefelt, U., Hellmann, C., Hornsten, P., Thorling, K. and Daugaard, G. (1996) "Outcome for patients with leukemia, multiple myeloma and lymphoma who relapse after high dose therapy and autologous stem cell support", Leuk. Lymphoma 24,81–91.
- Vose, J.M., Bierman, P.J., Anderson, JR., Kessinger, A., Pierson, J., Nelson, J., Frappier, B., Schmit-Pokorny, K., Weisenburger, D.D. and Armitage, J.O. (1992) "Progressive disease after high-dose therapy and autologous transplan-tation for lymphoid malignancy: clinical course and patient follow-up", Blood 15(80), 2142–2148.
- Recommendations for grading of acute and subacute toxic effects (WHO). (1985) In: WHO Handbook for reporting results of cancer treatment, Geneva, WHO Offset Publication No. 48.
- Tricot, G., Jagannath, S., Vesole, D.H., Crowley, J. and Barlogie, B. (1995) "Relapse of multiple myeloma after autologous transplantation: survival after salvage therapy", Bone Marrow Transplant. 16, 7–11.
- Ringden, O., Labopin, M., Gorki, N.C., Meloni, G., Blaise, D., Reiffers, J., Carlson, K., Fouillard, L. and Frassoni, E (2000) "The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)", Bone Marrow Transplant. 25, 1053–1058.
- de la Rubia, J., Sanz, C.F., Martin, G., Sempere, A., Picon, I., Carral, A., Larrea, L., Martinez, J., Soler, M.A., Bonanad, S., Lopez, E, Jarque, I. and Sanz, M.A. (1996) "Autologous bone marrow transplantation for patients with acute myeloblastic leukemia in relapse after autologous blood stem cell transplantation", Bone Marrow Transplant. 18, 1167–1173.
- Martinez, C., Carreras, E., Rovira, M., Urbano-Ispizua, A., Esteve, J., Fernandez-Aviles, F., Perales, M., Rives, S., Gomez, M. and Montserrat, E. (2001) "Allogenic stem cell transplantation as salvage therapy for patients relapsing after autologous transplantation: experience from a single insti-tution", Leuk. Res. 25, 379–384.
- Tsai, T., Goodman, S., Saez, R., Schiller, G., Adkins, D., Callander, N., Wolff, S. and Freytes, C.O. (1997) "Allogeneic bone marrow transplantation in patients who relapse after autologous transplantation", Bone Marrow Transplant. 20, 859–863.
- Godder, K.T., Metha, J., Chiang, K.Y., Adams, S., van Rhee, F., Singhal, S., Higgins-Smith, K., O'Neal, W., DeRienzo, S. and Henslee-Downey, J.P. (2001) "Partially mismatched related donor bone marrow transplantation as salvage for patients with AML who failed autologous stem cell transplant", Bone Marrow Transplant. 28, 1031–1036.
- Dey, B.R., McAfee, S., Sackstein, R., Colby, C., Saidman, S., Weymouth, D., Poliquin, C., Vanderklish, J., Sachs, D.H., Sykes, M. and Spitzer, T.R. (2001) "Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation", Biol. Blood Marrow Transplant. 7, 604–612.
- Porter, D.L., Luger, S.M., Duffy, K.M., Stadtmauer, E.A., Laport, G., Schuster, S.J., Orloff, G., Tsai, D., McDaid, K., Kathakali, A., Leonard, D.G. and Antin, J.H. (2001) "Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation", Biol. Blood Marrow Transplant. 7, 230–238.
- Vaishampayan, U., Karanes, C., Du, W., Varterasian, M. and al-Katib, A. (2002) "Outcome of relapsed non-Hodgkin's lymphoma patients after allogeneic and autologous transplantation", Cancer Investig. 20, 303–310.